近日,来自清华大学生命科学学院的科学团队自主研发出一种专门检测热休克蛋白90α的试剂盒。患者只需取一滴血,即可用于癌症病情监测和治疗效果评价。试剂盒已通过临床试验验证,并通过欧盟认证,获准进入中国和欧盟市场。
Scientists around the world are striving for effective detection of cancer in the early stages, and a Chinese scientist may have found a quick way of knowing whether malignant tumors exist in a patient's body, with just one drop of blood.
寻找癌症早期的有效检测手段是全世界科学家们为之努力的方向,而一位中国科学家可能已经找到一种快捷的方法,只需要一滴血,就可以判断病人体内是否存在恶性肿瘤。
Luo Yongzhang and his team in Tsinghua University's School of Life Sciences in Beijing have successfully invented a reagent test kit of Hsp90α for clinical use, which can diagnose multiple kinds of cancer by analyzing a drop of human blood.
来自清华大学生命科学学院的罗永章及其团队成功研发了一种临床用热休克蛋白90α试剂盒,它能通过分析一滴人体血液诊断各类癌症。
Malignant tumors in early phases can be cured but once they have spread all over the patient's body there is no way to save the person's life.
恶性肿瘤在早期阶段可以治愈,但一旦扩散到病人全身,就无药可医。
【重大突破!一滴血可测癌症,已被批准临床使用】相关文章:
★ QE3问答
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15